12:00 AM
Mar 15, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Cromafiban: Phase II

Phase I and early Phase II data show that cromafiban inhibits platelet aggregation in a dose and concentration dependent manner, and...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >